396 related articles for article (PubMed ID: 30935993)
41. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
[TBL] [Abstract][Full Text] [Related]
42. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
Chen HL; Wu SH; Hsu SH; Liou BY; Chen HL; Chang MH
J Biomed Sci; 2018 Oct; 25(1):75. PubMed ID: 30367658
[TBL] [Abstract][Full Text] [Related]
43. [Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3].
Cao LL; Yan JG; Feng DN; Dong Y; Xu ZQ; Wang FC; Gao YJ; Zhu SS; Zhang M
Zhonghua Er Ke Za Zhi; 2024 May; 62(5):462-466. PubMed ID: 38623015
[No Abstract] [Full Text] [Related]
44. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
45. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
de Vree JM; Jacquemin E; Sturm E; Cresteil D; Bosma PJ; Aten J; Deleuze JF; Desrochers M; Burdelski M; Bernard O; Oude Elferink RP; Hadchouel M
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):282-7. PubMed ID: 9419367
[TBL] [Abstract][Full Text] [Related]
46. Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects.
Bosma PJ; Wits M; Oude-Elferink RP
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383947
[TBL] [Abstract][Full Text] [Related]
47. Familial intrahepatic cholestasis: New and wide perspectives.
Vitale G; Gitto S; Vukotic R; Raimondi F; Andreone P
Dig Liver Dis; 2019 Jul; 51(7):922-933. PubMed ID: 31105019
[TBL] [Abstract][Full Text] [Related]
48. [Progressive familial intrahepatic cholestasis type 3].
Lipiński P; Jankowska I
Dev Period Med; 2018; 22(4):385-389. PubMed ID: 30636238
[TBL] [Abstract][Full Text] [Related]
49. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
Degiorgio D; Colombo C; Seia M; Porcaro L; Costantino L; Zazzeron L; Bordo D; Coviello DA
Eur J Hum Genet; 2007 Dec; 15(12):1230-8. PubMed ID: 17726488
[TBL] [Abstract][Full Text] [Related]
50. Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3.
Sun HZ; Shi H; Zhang SC; Shen XZ
World J Gastroenterol; 2015 Jan; 21(2):699-703. PubMed ID: 25593501
[TBL] [Abstract][Full Text] [Related]
51. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
[TBL] [Abstract][Full Text] [Related]
52. Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.
Lipiński P; Ciara E; Jurkiewicz D; Płoski R; Wawrzynowicz-Syczewska M; Pawłowska J; Jankowska I
Ann Hepatol; 2021; 25():100342. PubMed ID: 33757843
[TBL] [Abstract][Full Text] [Related]
53. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
[TBL] [Abstract][Full Text] [Related]
54. Biliary atresia combined with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Zhang BP; Huang ZH; Dong C
Medicine (Baltimore); 2019 May; 98(19):e15593. PubMed ID: 31083246
[TBL] [Abstract][Full Text] [Related]
55. Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
De Masi R; Orlando S; De Donno A
Ann Clin Transl Neurol; 2019 Nov; 6(11):2347-2350. PubMed ID: 31568708
[TBL] [Abstract][Full Text] [Related]
56. Comment on "Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
Weber ND; Martínez-García J; González-Aseguinolaza G
J Hepatol; 2022 Mar; 76(3):749-751. PubMed ID: 34626730
[No Abstract] [Full Text] [Related]
57. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
[TBL] [Abstract][Full Text] [Related]
58. Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids.
Blázquez-García I; Guerrero L; Cacho-Navas C; Djouder N; Millan J; Paradela A; Carmona-Rodríguez L; Corrales FJ
J Proteome Res; 2024 Apr; 23(4):1433-1442. PubMed ID: 38488493
[TBL] [Abstract][Full Text] [Related]
59. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
Trauner M; Fickert P; Wagner M
Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
[TBL] [Abstract][Full Text] [Related]
60. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH
World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
